Skip to content
OpenCapital
Get started

Zoetis ZTS Total products and services — Revenue

Other product segments

Horses
$5.8B+13.9%
Dogs and Cats
$1.35B+11.6%
Parasiticides
$586M+2.4%
Vaccines
$519M+18.2%
Cattle
$399M-0.5%
Dermatology
$349M-7.9%
Anti-infectives
$241M+1.3%
Pain and sedation
$203M-1.9%
Other pharmaceutical
$158M0.0%
Swine
$128M-7.9%
Animal health diagnostics
$117M+12.5%
Poultry
$117M-7.9%
Other Non Pharmaceuticals
$66M-7.0%
Fish
$65M+4.8%
Contract manufacturing & human health
$23M-23.3%
Sheep and other
$17M+6.3%

Similar metrics at other companies

Dolby Laboratories, Inc. logo
DLBProducts and services — Total Revenue
$23.39M-0.7%
NCR Atleos logo
NATLAll other products and services — Total Revenue
$289M+21.4%
Pitney Bowes logo
PBIProducts — Total Revenue
$88.65M-4.9%
Azenta logo
AZTAServices — Total Revenue
$107.15M+5.6%
NCR Voyix logo
VYXAll other products and services — Total Revenue
$187M-10.1%
Select Medical Holdings logo
SEMTotal patient services revenues — Revenue
$1.28B+4.8%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's total products and services — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's total products and services — revenue?
Zoetis (ZTS) reported total products and services — revenue of $2.24B in Q1 2026.
How has Zoetis's total products and services — revenue changed year-over-year?
Zoetis's total products and services — revenue increased by 3.3% year-over-year, from $2.17B to $2.24B.
What is the long-term trend for Zoetis's total products and services — revenue?
Over 4 years (2021 to 2025), Zoetis's total products and services — revenue has grown at a 4.9% compound annual growth rate (CAGR), from $7.69B to $9.33B.
What does total products and services — revenue mean?
This metric represents the aggregate gross revenue generated from the sale of all animal health products, including pharmaceuticals, vaccines, and diagnostic tools, alongside associated professional services. It serves as the primary top-line indicator for the company's total commercial output across both companion and production animal markets. By consolidating all revenue streams, it provides a comprehensive view of the firm's market penetration and overall demand for its diversified portfolio.